Carlyle Group Files 13D/A for QuidelOrtho
Ticker: CGABL · Form: SC 13D/A · Filed: Nov 21, 2024 · CIK: 1527166
| Field | Detail |
|---|---|
| Company | Carlyle Group Inc. (CGABL) |
| Form Type | SC 13D/A |
| Filed Date | Nov 21, 2024 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, sec-filing, investment-firm
Related Tickers: QDEL
TL;DR
Carlyle just updated its 13D on QuidelOrtho - ownership change incoming?
AI Summary
Carlyle Group Inc. filed an amendment to its Schedule 13D on November 21, 2024, related to its holdings in QuidelOrtho Corp. The filing indicates a change in beneficial ownership, though specific new holdings or disposal amounts are not detailed in this excerpt. Carlyle Group Inc. is a significant investment firm based in Washington, D.C.
Why It Matters
This filing signals a potential shift in the ownership structure or strategy concerning QuidelOrtho Corp., which could impact its stock performance and corporate governance.
Risk Assessment
Risk Level: medium — Schedule 13D filings often precede significant corporate actions or changes in control, which can introduce volatility.
Key Players & Entities
- Carlyle Group Inc. (company) — Filer of the Schedule 13D/A
- QuidelOrtho Corp (company) — Subject company of the filing
- 20241121 (date) — Date of filing
FAQ
What specific changes in beneficial ownership are reported in this 13D/A filing for QuidelOrtho Corp?
This excerpt does not detail the specific changes in beneficial ownership, only that an amendment to the Schedule 13D was filed on November 21, 2024.
Who is the subject company of this Schedule 13D/A filing?
The subject company is QuidelOrtho Corp, with Central Index Key 0001906324.
What is the filing date of this Schedule 13D/A amendment?
The filing date is November 21, 2024.
What is the primary business of QuidelOrtho Corp?
QuidelOrtho Corp is in the business of In Vitro & In Vivo Diagnostic Substances, with SIC code 2835.
What is the business address of Carlyle Group Inc. as listed in the filing?
The business address for Carlyle Group Inc. is C/O THE CARLYLE GROUP, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON, DC 20004.
Filing Details
This Form SC 13D/A (Form SC 13D/A) was filed with the SEC on November 21, 2024 regarding Carlyle Group Inc. (CGABL).